These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

871 related articles for article (PubMed ID: 29316426)

  • 1. Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer.
    Yaeger R; Chatila WK; Lipsyc MD; Hechtman JF; Cercek A; Sanchez-Vega F; Jayakumaran G; Middha S; Zehir A; Donoghue MTA; You D; Viale A; Kemeny N; Segal NH; Stadler ZK; Varghese AM; Kundra R; Gao J; Syed A; Hyman DM; Vakiani E; Rosen N; Taylor BS; Ladanyi M; Berger MF; Solit DB; Shia J; Saltz L; Schultz N
    Cancer Cell; 2018 Jan; 33(1):125-136.e3. PubMed ID: 29316426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis?
    Velho S; Moutinho C; Cirnes L; Albuquerque C; Hamelin R; Schmitt F; Carneiro F; Oliveira C; Seruca R
    BMC Cancer; 2008 Sep; 8():255. PubMed ID: 18782444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular alterations of Ras-Raf-mitogen-activated protein kinase and phosphatidylinositol 3-kinase-Akt signaling pathways in colorectal cancers from a tertiary hospital at Kuala Lumpur, Malaysia.
    Yip WK; Choo CW; Leong VC; Leong PP; Jabar MF; Seow HF
    APMIS; 2013 Oct; 121(10):954-66. PubMed ID: 23992303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRAF, PIK3CA, and HER2 Oncogenic Alterations According to KRAS Mutation Status in Advanced Colorectal Cancers with Distant Metastasis.
    Nam SK; Yun S; Koh J; Kwak Y; Seo AN; Park KU; Kim DW; Kang SB; Kim WH; Lee HS
    PLoS One; 2016; 11(3):e0151865. PubMed ID: 26991109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNF43 mutation is associated with aggressive tumor biology along with BRAF V600E mutation in right-sided colorectal cancer.
    Matsumoto A; Shimada Y; Nakano M; Oyanagi H; Tajima Y; Nakano M; Kameyama H; Hirose Y; Ichikawa H; Nagahashi M; Nogami H; Maruyama S; Takii Y; Ling Y; Okuda S; Wakai T
    Oncol Rep; 2020 Jun; 43(6):1853-1862. PubMed ID: 32236609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Chilean patients with sporadic colorectal cancer according to the three main carcinogenic pathways: Microsatellite instability, CpG island methylator phenotype and Chromosomal instability.
    Wielandt AM; Hurtado C; Moreno C M; Villarroel C; Castro M; Estay M; Simian D; Martinez M; Vial MT; Kronberg U; López-Köstner F
    Tumour Biol; 2020 Jul; 42(7):1010428320938492. PubMed ID: 32635826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNF43 and ZNRF3 are commonly altered in serrated pathway colorectal tumorigenesis.
    Bond CE; McKeone DM; Kalimutho M; Bettington ML; Pearson SA; Dumenil TD; Wockner LF; Burge M; Leggett BA; Whitehall VL
    Oncotarget; 2016 Oct; 7(43):70589-70600. PubMed ID: 27661107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation.
    Yan HHN; Lai JCW; Ho SL; Leung WK; Law WL; Lee JFY; Chan AKW; Tsui WY; Chan ASY; Lee BCH; Yue SSK; Man AHY; Clevers H; Yuen ST; Leung SY
    Gut; 2017 Sep; 66(9):1645-1656. PubMed ID: 27329244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRAF mutation predicts for poor outcomes after metastasectomy in patients with metastatic colorectal cancer.
    Yaeger R; Cercek A; Chou JF; Sylvester BE; Kemeny NE; Hechtman JF; Ladanyi M; Rosen N; Weiser MR; Capanu M; Solit DB; D'Angelica MI; Vakiani E; Saltz LB
    Cancer; 2014 Aug; 120(15):2316-24. PubMed ID: 24737664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRAF V600E mutation and KRAS codon 13 mutations predict poor survival in Chinese colorectal cancer patients.
    Chen J; Guo F; Shi X; Zhang L; Zhang A; Jin H; He Y
    BMC Cancer; 2014 Nov; 14():802. PubMed ID: 25367198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next-generation sequencing reveals heterogeneous genetic alterations in key signaling pathways of mismatch repair deficient colorectal carcinomas.
    Wang J; Li R; He Y; Yi Y; Wu H; Liang Z
    Mod Pathol; 2020 Dec; 33(12):2591-2601. PubMed ID: 32620917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic mutations and microsatellite instability phenotype predict specific anatomical subsite in colorectal cancer patients.
    Corso G; Pascale V; Flauti G; Ferrara F; Marrelli D; Roviello F
    Eur J Hum Genet; 2013 Dec; 21(12):1383-8. PubMed ID: 23572025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wild-type APC Is Associated with Poor Survival in Metastatic Microsatellite Stable Colorectal Cancer.
    Wang C; Ouyang C; Cho M; Ji J; Sandhu J; Goel A; Kahn M; Fakih M
    Oncologist; 2021 Mar; 26(3):208-214. PubMed ID: 33230914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the WTX-gene are found in some high-grade microsatellite instable (MSI-H) colorectal cancers.
    Scheel SK; Porzner M; Pfeiffer S; Ormanns S; Kirchner T; Jung A
    BMC Cancer; 2010 Aug; 10():413. PubMed ID: 20696052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic alterations in signet ring and mucinous patterned colorectal carcinoma.
    Kim H; Kim BH; Lee D; Shin E
    Pathol Res Pract; 2019 Oct; 215(10):152566. PubMed ID: 31400926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KRAS mutated colorectal cancers with or without PIK3CA mutations: Clinical and molecular profiles inform current and future therapeutics.
    Voutsadakis IA
    Crit Rev Oncol Hematol; 2023 Jun; 186():103987. PubMed ID: 37059275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in DNA damage repair gene mutations between left- and right-sided colorectal cancer.
    Huang W; Li W; Xu N; Li H; Zhang Z; Zhang X; He T; Yao J; Xu M; He Q; Guo L; Zhang S
    Cancer Med; 2023 May; 12(9):10187-10198. PubMed ID: 37096801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Genomic Landscapes in Early and Later Onset Colorectal Cancer.
    Lieu CH; Golemis EA; Serebriiskii IG; Newberg J; Hemmerich A; Connelly C; Messersmith WA; Eng C; Eckhardt SG; Frampton G; Cooke M; Meyer JE
    Clin Cancer Res; 2019 Oct; 25(19):5852-5858. PubMed ID: 31243121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AKT1 E17K in Colorectal Carcinoma Is Associated with BRAF V600E but Not MSI-H Status: A Clinicopathologic Comparison to PIK3CA Helical and Kinase Domain Mutants.
    Hechtman JF; Sadowska J; Huse JT; Borsu L; Yaeger R; Shia J; Vakiani E; Ladanyi M; Arcila ME
    Mol Cancer Res; 2015 Jun; 13(6):1003-8. PubMed ID: 25714871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular spectrum of KRAS, BRAF, and PIK3CA gene mutation: determination of frequency, distribution pattern in Indian colorectal carcinoma.
    Bisht S; Ahmad F; Sawaimoon S; Bhatia S; Das BR
    Med Oncol; 2014 Sep; 31(9):124. PubMed ID: 25073438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.